New Delhi [India], August 16: Micro Labs Ltd, a renowned pharmaceutical company, proudly announced the launch of Trisopt, the world's first fixed-dose combination of Brimonidine, Timolol, and Brinzolamide ophthalmic suspension for glaucoma management. Trisopt is an indigenous development fro
According to a recent study from the Boston Medical Centre, there is a connection between biomarkers found in the vitreous humour of the eye and pathologically confirmed cases of Alzheimer's disease (AD) and Chronic Traumatic Encephalopathy (CTE) in post-mortem brain and eye tissue.
A damaged optic nerve underlies the neurodegenerative illness glaucoma, which results in visual loss and eventual blindness. Glaucoma affects more than 2,00,000 persons in the United States annually. Regrettably, there is no cure at this time. Researchers discovered that neurons use mitochon
New Delhi [India], February 21 (ANI/PNN): Sukhdeep Singh Aasht, organized "Global Inclusivity Run for Awareness of Glaucoma by visually impaired". Around 2800 Visually Impaired along with Guides took confident step forward across 62 countries/regions, leading to Glaucoma awareness to over
A multinational research team led by Lithuanian specialists adds to the body of evidence showing that intracranial pressure plays a substantial role in normal-tension glaucoma, which makes up to 50 per cent of all cases of glaucoma. Low intracranial pressure is linked to poor patient vision,
An international team of researchers led by Lithuanian scientists provide additional evidence that intracranial pressure plays an important role in normal-tension glaucoma, which accounts for up to 50 per cent of all glaucoma cases. A recent clinical study demonstrates that low intracranial
Pune (Maharashtra) [India], January 6 (ANI/PNN): Pune-based Jehangir Hospital has enhanced the scope of its Ophthalmology department with the launch of its latest Ophthalmology Centre. The department is a dedicated stop for adult and paediatric vision care. It houses a team of highly experie
A team of scientists has discovered a new genetic mutation that maybe a root cause of severe cases of childhood glaucoma, a devastating condition that runs in families and can rob children of their vision by 3 years of age.
An international team of researchers led by Mass Eye and Ear, a member of Mass General Brigham and Boston Children's Hospital, has discovered a new genetic mutation that could be the root cause of severe cases of childhood glaucoma, a devastating condition that runs in families and can rob c
Researchers have identified new genetic mutation which may be the cause of server cases in patients with childhood glaucoma, a debilitating condition that runs in families and can cause blindness in children as young as three years old.
An international team of scientists led by Mass Eye and Ear, a member of Mass General Brigham, and Boston Children's Hospital, has discovered a new genetic mutation that may be a root cause of severe cases of childhood glaucoma, a devastating condition that runs in families and can rob child